Results 31 to 40 of about 958,574 (141)
The road ahead for stem cell therapies in type 1 diabetes
Abstract Aims Type 1 diabetes results from autoimmune destruction of insulin‐producing pancreatic β‐cells. Although exogenous insulin remains the standard treatment, it does not restore physiological glucose regulation. Differentiation of human pluripotent stem cells into β‐cells offers a scalable alternative to cadaveric islet transplantation and has ...
Rosa Gasa +2 more
wiley +1 more source
Binuclear ruthenium complexes inhibit the fibril formation of human islet amyloid polypeptide
Binuclear ruthenium complexes reverse the aggregation of human islet amyloid polypeptide.
Gehui Gong, Weihong Du, Wenji Wang
core +1 more source
Human Islet Amyloid Polypeptide Fibril Binding to Catalase: A Transmission Electron Microscopy and Microplate Study [PDF]
The diabetes-associated human islet amyloid polypeptide (IAPP) is a 37-amino-acid peptide that forms fibrils in vitro and in vivo. Human IAPP fibrils are toxic in a similar manner to Alzheimer's amyloid-β (Aβ) and prion protein (PrP) fibrils.
Nathaniel G. N. Milton +3 more
core +1 more source
Plasma amylin levels in migraine and after erenumab treatment: A REFORM study
Plain Language Summary Researchers are searching for blood tests that can show what is happening in migraine and help predict who will benefit from preventive treatment, and blood amylin (a signaling molecule known to trigger migraine) has been shown to be elevated in people with chronic migraine.
Rogelio Domínguez‐Moreno +8 more
wiley +1 more source
Translating gut microbiome research into therapies for type 1 diabetes
Abstract Type 1 diabetes (T1D) is characterised by the loss of functional pancreatic β‐cells, for which lifelong insulin therapy remains the standard of care. Given that the gut microbiome can influence host health and that shifts in gut microbial profiles have been observed in T1D, growing interest has emerged in the role of the gut microbiome in T1D,
Shanti P. Kok +2 more
wiley +1 more source
Innovations in Obesity Treatment: Beyond Adipose Tissue Dysfunction
Obesity drives chronic inflammation, insulin resistance, type 2 diabetes, and cancer development through adipocyte dysfunction. Addressing this multisystemic disorder requires integrated strategies beyond diet and exercise, such as thermogenesis activation via menthol or capsinoids and appetite control through GLP‐1/GIP agonists and neuromodulation to ...
Jesica Martínez‐Godfrey +7 more
wiley +1 more source
Islet amyloid polypeptide (IAPP, “amylin”) has been proposed as having important roles in the pathogenesis of type 2 diabetes mellitus via its biological activity and by forming islet amyloid.
Ma, Zhi, +9 more
core +1 more source
Dataset of the BEMD data used in the paper "The influence of the choice of force field on the conformational landscape of monomeric rat and human islet amyloid ...
Moore, Sandra Jayne +2 more
core +1 more source
Insulin based inhibitors of human islet amyloid polypeptide (hIAPP) and their effect on hIAPP- mediated membrane damage in type 2 diabetes mellitus [PDF]
Amylin (Islet Amyloid Polypeptide, IAPP) is a 37 amino acid polypeptide, co-secreted with insulin from pancreatic beta cells, that plays a role in the damage of cell membranes by forming amyloid fibrils in Type 2 diabetes.
Peddi, Durgaprasad
core +1 more source
ABSTRACT Post‐translational modifications (PTMs) chemically diversify the ~20,000 genomically encoded proteins into millions of functional variants, and this diversity has profound consequences for T cell‐mediated immune responses. PTM‐reactive T cells have been identified across numerous autoimmune diseases and, in several cases, implicated directly ...
Sanya Arshad +2 more
wiley +1 more source

